ClinVar Miner

Submissions for variant NM_000404.4(GLB1):c.435TCT[1] (p.Leu147del)

dbSNP: rs751033858
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002005188 SCV002261771 likely pathogenic Mucopolysaccharidosis, MPS-IV-B; GM1 gangliosidosis 2024-07-09 criteria provided, single submitter clinical testing This variant, c.438_440del, results in the deletion of 1 amino acid(s) of the GLB1 protein (p.Leu147del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs751033858, gnomAD 0.005%). This variant has been observed in individual(s) with GM1 gangliosidosis and/or mucopolysaccharidosis type IVB (PMID: 17309651, 29800929). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Fulgent Genetics, Fulgent Genetics RCV005025561 SCV005658117 pathogenic GM1 gangliosidosis type 2; GM1 gangliosidosis type 3; Mucopolysaccharidosis, MPS-IV-B; Infantile GM1 gangliosidosis 2024-03-07 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.